Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?

by Fay, Andre P., Antonarakis, Emmanuel S.
Published in Ann Transl Med (2019)

Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell re...

by Haaland, Benjamin, Chopra, Akhil, Acharyya, Sanchalika, Fay, André P, Lopes, Gilberto de Lima
Published 2014

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database

by Fay, Andre P., McKay, Rana R., Lin, Xun, Simantov, Ronit, Choueiri, Toni K.
Published in J Glob Oncol (2018)

10% Tumor Diameter Shrinkage on the First Follow-Up Computed Tomography Predicts Clinical Outcome in Patients With Advanced Renal Cell Carcinoma Treated With Angiogenesis Inhibitor...

by Krajewski, Katherine M., Franchetti, Yoko, Nishino, Mizuki, Fay, André P., Ramaiya, Nikhil, Van den Abbeele, Annick D., Choueiri, Toni K.
Published 2014

Adrenocortical Carcinoma: The Management of Metastatic Disease

by Fay, André P., Elfiky, Aymen, Teló, Gabriela H., McKay, Rana R., Kaymakcalan, Marina, Nguyen, Paul L., Vaidya, Anand, Ruan, Daniel T., Bellmunt, Joaquim, Choueiri, Toni K.
Published in Crit Rev Oncol Hematol (2014)

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials

by Moreira, Raphael B., Debiasi, Marcio, Francini, Edoardo, Nuzzo, Pier V., Velasco, Guillermo De, Maluf, Fernando C., Fay, Andre P., Bellmunt, Joaquim, Choueiri, Toni K., Schutz, Fabio A.
Published in Oncotarget (2017)

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothe...

by Bellmunt, Joaquim, Werner, Lillian, Leow, Jeffrey J., Mullane, Stephanie A., Fay, André P., Riester, Markus, Van Hummelen, Paul, Taplin, Mary-Ellen, Choueiri, Toni K., Van Allen, Eliezer, Rosenberg, Jonathan
Published in PLoS One (2015)

BRAF mutations in metanephric adenoma of the kidney

by Choueiri, Toni K., Cheville, John, Palescandolo, Emanuele, Fay, Andre P., Kantoff, Philip W., Atkins, Michael B., McKenney, Jesse K., Brown, Victoria, Lampron, Megan E., Zhou, Ming, Hirsch, Michelle S., Signoretti, Sabina
Published in Eur Urol (2012)

The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma

by Choueiri, Toni K., Fay, André P., Gagnon, Robert, Lin, Ying, Bahamon, Brittany, Brown, Victoria, Rosenberg, Jonathan E., Hutson, Thomas E., Baker-Neblett, Katherine L., Carpenter, Christopher, Liu, Yuan, Pandite, Lini, Signoretti, Sabina
Published in Clin Cancer Res (2013)

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy

by Bellmunt, Joaquim, Zhou, Chensheng Willa, Mullane, Stephanie A, Werner, Lillian, Taplin, Mary-Ellen, Fay, André P, Choueiri, Toni K, Orsola, Anna, Takeda, David Y, Hahn, William C, Kim, Jaegil, Sonpavde, Guru, Bowden, Michaela
Published in Br J Cancer (2016)

Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma

by de Velasco, Guillermo, Gray, Kathryn P., Hamieh, Lana, Urun, Yuksel, Carol, Hallie A., Fay, Andre P., Signoretti, Sabina, Kwiatkowski, David J., McDermott, David F., Freedman, Matthew, Pomerantz, Mark M., Choueiri, Toni K.
Published in Eur Urol Focus (2016)

Differential expression of PD-L1 between primary and metastatic sites in clear cell Renal Cell Carcinoma

by Callea, Marcella, Albiges, Laurence, Gupta, Mamta, Cheng, Su-Chun, Genega, Elizabeth M., Fay, André P., Song, Jiaxi, Carvo, Ingrid, Bhatt, Rupal S., Atkins, Michael B., Hodi, F. Stephen, Choueiri, Toni K., McDermott, David F., Freeman, Gordon J., Signoretti, Sabina
Published in Cancer Immunol Res (2015)

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

by Fay, André P, Signoretti, Sabina, Callea, Marcella, Telό, Gabriela H, McKay, Rana R, Song, Jiaxi, Carvo, Ingrid, Lampron, Megan E, Kaymakcalan, Marina D, Poli-de-Figueiredo, Carlos E, Bellmunt, Joaquim, Hodi, F Stephen, Freeman, Gordon J, Elfiky, Aymen, Choueiri, Toni K
Published in J Immunother Cancer (2015)

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model

by de Velasco, Guillermo, Culhane, Aedín C., Fay, André P., Hakimi, A. Ari, Voss, Martin H., Tannir, Nizar M., Tamboli, Pheroze, Appleman, Leonard J., Bellmunt, Joaquim, Kimryn Rathmell, W., Albiges, Laurence, Hsieh, James J., Heng, Daniel Y. C., Signoretti, Sabina, Choueiri, Toni K.
Published in Oncologist (2017)

Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma

by Fay, Andre P., de Velasco, Guillermo, Ho, Thai H., Van Allen, Eliezer M., Murray, Bradley, Albiges, Laurence, Signoretti, Sabina, Hakimi, A. Ari, Stanton, Melissa L., Bellmunt, Joaquim, McDermott, David F., Atkins, Michael B., Garraway, Levi A., Kwiatkowski, David J., Choueiri, Toni K.
Published in J Natl Compr Canc Netw (2016)

Identification of ALK Gene Alterations in Urothelial Carcinoma

by Bellmunt, Joaquim, Selvarajah, Shamini, Rodig, Scott, Salido, Marta, de Muga, Silvia, Costa, Irmgard, Bellosillo, Beatriz, Werner, Lillian, Mullane, Stephanie, Fay, André P., O'Brien, Robert, Barretina, Jordi, Minoche, André E., Signoretti, Sabina, Montagut, Clara, Himmelbauer, Heinz, Berman, David M., Kantoff, Philip, Choueiri, Toni K., Rosenberg, Jonathan E.
Published 2014

HER2 as a target in invasive urothelial carcinoma

by Bellmunt, Joaquim, Werner, Lillian, Bamias, Aristotle, Fay, André P, Park, Rachel S, Riester, Markus, Selvarajah, Shamini, Barletta, Justine A, Berman, David M, de Muga, Silvia, Salido, Marta, Gallardo, Enrique, Rojo, Federico, Guancial, Elizabeth A, Bambury, Richard, Mullane, Stephanie A, Choueiri, Toni K, Loda, Massimo, Stack, Edward, Rosenberg, Jonathan
Published in Cancer Med (2015)

Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic Renal Cell Carcinoma

by Kwiatkowski, David J., Choueiri, Toni K., Fay, André P., Rini, Brian I., Thorner, Aaron R., de Velasco, Guillermo, Tyburczy, Magdalena E., Hamieh, Lana, Albiges, Laurence, Agarwal, Neeraj, Ho, Thai H., Song, Jiaxi, Pignon, Jean-Christophe, Barrios, Pablo M., Michaelson, M. Dror, Van Allen, Eliezer, Krajewski, Katherine M., Porta, Camillo, Pal, Sumanta, Bellmunt, Joaquim, McDermott, David F., Heng, Daniel Y. C., Gray, Kathryn P., Signoretti, Sabina
Published in Clin Cancer Res (2016)

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma

by McKay, Rana R., Bossé, Dominick, Xie, Wanling, Wankowicz, Stephanie A.M., Flaifel, Abdallah, Brandao, Raphael, Lalani, Aly-Khan A., Martini, Dylan J., Wei, Xiao X., Braun, David A., Van Allen, Eliezer, Castellano, Daniel, De Velasco, Guillermo, Wells, J. Connor, Heng, Daniel Y., Fay, Andre P., Schutz, Fabio A., Hsu, JoAnn, Pal, Sumanta K., Lee, Jae Lyun, Hsieh, James J., Harshman, Lauren C., Signoretti, Sabina, Motzer, Robert J., Feldman, Darren, Choueiri, Toni K.
Published in Cancer Immunol Res (2018)

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

by Albiges, Laurence, Hakimi, A. Ari, Xie, Wanling, McKay, Rana R., Simantov, Ronit, Lin, Xun, Lee, Jae-Lyun, Rini, Brian I., Srinivas, Sandy, Bjarnason, Georg A., Ernst, Scott, Wood, Lori A., Vaishamayan, Ulka N., Rha, Sun-Young, Agarwal, Neeraj, Yuasa, Takeshi, Pal, Sumanta K., Bamias, Aristotelis, Zabor, Emily C., Skanderup, Anders J., Furberg, Helena, Fay, Andre P., de Velasco, Guillermo, Preston, Mark A., Wilson, Kathryn M., Cho, Eunyoung, McDermott, David F., Signoretti, Sabina, Heng, Daniel Y.C., Choueiri, Toni K.
Published in J Clin Oncol (2016)